Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tram T Tran

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2009
Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipientsNorah A Terrault, Tram T Tran, Eugene Schiff, et al.
The American Journal of Gastroenterology|September 4, 2007
Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patientsOmid A Shaye, Michael Yadegari, Maria T Abreu, et al.
Journal of Gastroenterology and Hepatology|March 3, 2006
Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donorsTram T Tran, Chanikarn Changsri, C R Shackleton, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 17, 2011
Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patientNicholas N Nissen, Vijay Menon, Catherine Bresee, et al.
The American Journal of Gastroenterology|July 5, 2006
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnessesGil Y Melmed, Andrew F Ippoliti, Konstantinos A Papadakis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 18, 2017
The Braden Scale, A standard tool for assessing pressure ulcer risk, predicts early outcomes after liver transplantationVinay Sundaram, Jane Lim, Danielle M Tholey, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 13, 2006
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinomaStephen N Wong, K Rajender Reddy, Emmet B Keeffe, et al.
Annals of Hepatology|June 9, 2020
Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis BMauricio Lisker-Melman, Mandana Khalili, Steven H Belle, et al.
Journal of Viral Hepatitis|June 20, 2019
Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infectionTarik Asselah, Stephen D Shafran, Stefan Bourgeois, et al.
Annals of Internal Medicine|November 10, 2015
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized TrialGregory T Everson, William J Towner, Mitchell N Davis, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2009
Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipientsNorah A Terrault, Tram T Tran, Eugene Schiff, et al.
The American Journal of Gastroenterology|September 4, 2007
Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patientsOmid A Shaye, Michael Yadegari, Maria T Abreu, et al.
Journal of Gastroenterology and Hepatology|March 3, 2006
Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donorsTram T Tran, Chanikarn Changsri, C R Shackleton, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 17, 2011
Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patientNicholas N Nissen, Vijay Menon, Catherine Bresee, et al.
The American Journal of Gastroenterology|July 5, 2006
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnessesGil Y Melmed, Andrew F Ippoliti, Konstantinos A Papadakis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 18, 2017
The Braden Scale, A standard tool for assessing pressure ulcer risk, predicts early outcomes after liver transplantationVinay Sundaram, Jane Lim, Danielle M Tholey, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 13, 2006
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinomaStephen N Wong, K Rajender Reddy, Emmet B Keeffe, et al.
Annals of Hepatology|June 9, 2020
Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis BMauricio Lisker-Melman, Mandana Khalili, Steven H Belle, et al.
Journal of Viral Hepatitis|June 20, 2019
Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infectionTarik Asselah, Stephen D Shafran, Stefan Bourgeois, et al.
Annals of Internal Medicine|November 10, 2015
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized TrialGregory T Everson, William J Towner, Mitchell N Davis, et al.
Pageof 7